title: Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells.
abstract: The effects of morphine are mediated mainly through the mu opioid receptor (MOR). Expression of the MOR is up-regulated during neuronal differentiation in P19 embryonal carcinoma cells and epigenetic changes play an important role in MOR up-regulation. This study investigates the basis for differentiation-dependent alterations of MOR chromatin by studying the recruitment or dissociation of several factors to the remodeled chromatin locus. Chromatin immunoprecipitation assays were used to demonstrate the recruitment of the transcriptional activator Sp1 and the chromatin remodeling factors Brg1 and BAF155 to this promoter, as well as the dissociation of repressors [histone deacetylases, mSin3A, Brm, and methyl-CpG-binding protein 2 (MeCP2)]. Histone modifications (acetylation, induction of histone H3-lys4 methylation, and reduction of H3-lys9 methylation) were consistently detected on this promoter. Overexpression of Sp1 strongly enhanced MOR promoter activity, and the histone deacetylase inhibitor trichostatin A also increased promoter activity. In vitro DNA CpG-methylation of the promoter partially blocked binding of the Sp1 factor but induced MeCP2 binding. Coimmunoprecipitation studies also found novel evidence of an endogenous MeCP2 interaction with Sp3 but a weaker interaction with Sp1. Overall, the results suggest that during neuronal differentiation, MeCP2 and DNA methylation mediate remodeling of the MOR promoter by chromatin remodeling factors (Brg1 and BAF155) from a compacted state to a conformation allowing access for transcriptional factors. Subsequent recruitment of the activating transcription factor Sp1 to the remodeled promoter results in MOR up-regulation.
authors.affiliation: Department of Pharmacology, University of Minnesota, 6-120 Jackson Hall, 321 Church St. S.E., Minneapolis, MN 55455, USA. hwang025@umn.edu
authors.forename: Cheol Kyu
authors.initials: CK
authors.lastname: Hwang
authors.forename: Chun Sung
authors.initials: CS
authors.lastname: Kim
authors.forename: Do Kyung
authors.initials: DK
authors.lastname: Kim
authors.forename: Ping-Yee
authors.initials: PY
authors.lastname: Law
authors.forename: Li-Na
authors.initials: LN
authors.lastname: Wei
authors.forename: Horace H
authors.initials: HH
authors.lastname: Loh
mesh_terms: D000818:Animals; D001483:Base Sequence; D002454:Cell Differentiation; D045744:Cell Line, Tumor; D002843:Chromatin / Q000378:metabolism*; D047369:Chromatin Immunoprecipitation; D017931:DNA Primers; D024202:Electrophoretic Mobility Shift Assay; D051379:Mice; D009474:Neurons / Q000166:cytology / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D017450:Receptors, Opioid, mu / Q000235:genetics*; D014157:Transcription Factors / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: D002843:Chromatin; D017931:DNA Primers; D017450:Receptors, Opioid, mu; D014157:Transcription Factors
references.citation: Mol Pharmacol. 2003 Dec;64(6):1410-8
references.pmid: 14645671
references.citation: Ann N Y Acad Sci. 2007 Apr;1100:299-305
references.pmid: 17460191
references.citation: Bioessays. 2003 Dec;25(12):1192-200
references.pmid: 14635254
references.citation: Science. 2003 Oct 31;302(5646):890-3
references.pmid: 14593184
references.citation: J Neurochem. 1996 Oct;67(4):1352-9
references.pmid: 8858915
references.citation: Biochem Biophys Res Commun. 2006 May 19;343(4):1132-40
references.pmid: 16580639
references.citation: Mol Cell Biol. 2007 Jul;27(13):4720-36
references.pmid: 17452465
references.citation: Cell Mol Life Sci. 2009 Sep;66(17):2933-42
references.pmid: 19609488
references.citation: Mol Pharmacol. 2005 May;67(5):1674-83
references.pmid: 15703380
references.citation: Cell. 1992 Feb 7;68(3):561-72
references.pmid: 1346755
references.citation: Nat Genet. 2006 Sep;38(9):962-4; author reply 964-7
references.pmid: 16940996
references.citation: Cell. 1988 Dec 2;55(5):887-98
references.pmid: 3142690
references.citation: Brain Res Mol Brain Res. 1998 Mar 1;54(2):321-6
references.pmid: 9555078
references.citation: Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1544-9
references.pmid: 9037090
references.citation: Histol Histopathol. 2007 Mar;22(3):311-9
references.pmid: 17163405
references.citation: Epigenetics. 2008 Mar-Apr;3(2):64-8
references.pmid: 18437052
references.citation: Cell. 2002 Mar 8;108(5):587-90
references.pmid: 11893329
references.citation: Cell. 2000 Mar 31;101(1):79-89
references.pmid: 10778858
references.citation: J Cell Mol Med. 2010 May;14(5):1113-24
references.pmid: 19438807
references.citation: EMBO J. 2002 Jul 1;21(13):3377-89
references.pmid: 12093739
references.citation: Genome Biol. 2003;4(2):206
references.pmid: 12620113
references.citation: J Neurosci. 2005 Mar 30;25(13):3350-7
references.pmid: 15800190
references.citation: Biochem Biophys Res Commun. 1997 May 19;234(2):351-7
references.pmid: 9177274
references.citation: Nat Genet. 2005 Mar;37(3):254-64
references.pmid: 15696166
references.citation: FASEB J. 2007 Dec;21(14):3963-73
references.pmid: 17625070
references.citation: Physiology (Bethesda). 2006 Dec;21:404-10
references.pmid: 17119153
references.citation: Int J Oncol. 2004 Mar;24(3):719-24
references.pmid: 14767558
references.citation: Nucleic Acids Res. 1983 Mar 11;11(5):1475-89
references.pmid: 6828386
references.citation: Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9081-5
references.pmid: 8090773
references.citation: J Biol Chem. 2002 Mar 22;277(12):9780-9
references.pmid: 11773047
references.citation: J Cell Mol Med. 2009 Sep;13(9B):3591-615
references.pmid: 19602036
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14084-9
references.pmid: 11717463
references.citation: Genes Dev. 2001 Mar 1;15(5):603-18
references.pmid: 11238380
references.citation: J Neurosci. 1998 Apr 1;18(7):2538-49
references.pmid: 9502813
references.citation: Nat Rev Mol Cell Biol. 2003 Oct;4(10):809-14
references.pmid: 14570061
references.citation: Nucleic Acids Res. 2006;34(22):6392-403
references.pmid: 17130167
references.citation: Biochim Biophys Acta. 2008 Oct;1783(10):1835-46
references.pmid: 18657578
references.citation: Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):66-74
references.pmid: 15722796
references.citation: Curr Med Chem. 2006;13(24):2909-19
references.pmid: 17073637
references.citation: Methods Enzymol. 1987;152:721-35
references.pmid: 3309570
references.citation: Mol Cell Proteomics. 2008 Aug;7(8):1517-29
references.pmid: 18453338
references.citation: Neuroscience. 1999;92(3):1143-55
references.pmid: 10426553
references.citation: J Biol Chem. 2001 Apr 20;276(16):12774-80
references.pmid: 11278523
references.citation: Gene. 1999 Oct 1;238(2):291-300
references.pmid: 10570957
references.citation: J Biol Chem. 1998 Oct 16;273(42):27678-85
references.pmid: 9765304
references.citation: Annu Rev Pharmacol Toxicol. 2000;40:389-430
references.pmid: 10836142
references.citation: Curr Opin Pharmacol. 2002 Feb;2(1):69-75
references.pmid: 11786311
references.citation: Neuron. 2007 Jul 19;55(2):201-15
references.pmid: 17640523
references.citation: Nucleic Acids Res. 2007;35(5):1501-13
references.pmid: 17284463
references.citation: J Biol Chem. 2004 May 7;279(19):19764-74
references.pmid: 14998994
references.citation: J Biol Chem. 2004 Nov 5;279(45):46464-73
references.pmid: 15322094
references.citation: Trends Neurosci. 1995 Jan;18(1):22-9
references.pmid: 7535487
references.citation: Development. 2005 Jan;132(1):105-15
references.pmid: 15576411
references.citation: Cell. 2004 Sep 3;118(5):555-66
references.pmid: 15339661
references.citation: Cancer Biol Ther. 2004 Sep;3(9):825-30
references.pmid: 15492497
references.citation: Nature. 1996 Oct 31;383(6603):819-23
references.pmid: 8893006
references.citation: J Biol Chem. 2001 Nov 23;276(47):43901-8
references.pmid: 11572871
references.citation: Brain Res Mol Brain Res. 2003 Apr 10;112(1-2):153-62
references.pmid: 12670713
references.citation: J Biol Chem. 2003 Feb 7;278(6):3742-50
references.pmid: 12446692
references.citation: J Embryol Exp Morphol. 1972 Apr;27(2):353-65
references.pmid: 4625067
references.citation: J Neurochem. 1995 Oct;65(4):1636-45
references.pmid: 7561859
references.citation: J Cell Biochem. 2005 Jun 1;95(3):466-77
references.pmid: 15832342
references.citation: Trends Endocrinol Metab. 2007 Jul;18(5):215-24
references.pmid: 17544291
references.citation: Oncogene. 2001 May 28;20(24):3007-13
references.pmid: 11420715
references.citation: Brain Res Mol Brain Res. 2002 Aug 15;104(2):184-93
references.pmid: 12225873
references.citation: Neuropharmacology. 2004;47 Suppl 1:300-11
references.pmid: 15464146
references.citation: Mol Cell Biol. 2001 Feb;21(4):1155-63
references.pmid: 11158302
references.citation: Mol Pharmacol. 2003 Oct;64(4):876-84
references.pmid: 14500744